Meriem Bouslouk

Company: G-BA / Federal Joint Committee
Meriem

As a desk officer in the pharmaceuticals department of the G-BA, Dr. Bouslouk’s field of expertise focuses on the early benefit assessment of pharmaceuticals under AMNOG, the new German Act on the Reform of the Market for Medicinal Products. Her main tasks include preparing and presenting documents for the pharmaceuticals subcommittee with an emphasis on orphan drugs, liaising with the pharmaceutical industry, and representing the G-BA at international events.